2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$13.02-$0.20 (-1.48%)
Price as of Oct 02, 2026 5:42 PM EDT- $375.5MMarket Cap
- -39.63%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$13.02-$0.20 (-1.48%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.21 | ||
Change | -$0.48 (-3.51%) | ||
Open | $13.49 | ||
High | $13.87 | ||
Low | $13.18 | ||
Previous Close | $13.69 | ||
Volume | 497,333 | ||
30-Day Average Volume | 880,195 | ||
1-Week Change | -6.44% | ||
1-Month Change | -18.58% | ||
1-Year Change | -39.63% | ||
3-Year Change | -48.30% | ||
5-Year Change | -70.26% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $224.3M | ||
Market Cap | $375.5M | ||
Enterprise Value | $184.0M | ||
Period: QTR TTM FY | |||
Revenue | $880,000.00 | ||
Net Income | -$23.8M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$23.8M | ||
EBITDA | -$23.1M | ||
Net Working Capital | $163.6M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 209 | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue